Cargando…
The First Metabolome Analysis in Children with Epilepsy and ALG13-CDG Resulting from c.320A>G Variant
Background: ALG13-CDG belongs to the congenital disorders of glycosylation (CDG), which is an expanding group of multisystemic metabolic disorders caused by the N-linked, O-linked oligosaccharides, shared substrates, glycophosphatidylinositol (GPI) anchors, and dolichols pathways with high genetic h...
Autores principales: | Paprocka, Justyna, Jezela-Stanek, Aleksandra, Boguszewicz, Łukasz, Sokół, Maria, Lipiński, Patryk, Jamroz, Ewa, Emich-Widera, Ewa, Tylki-Szymańska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004727/ https://www.ncbi.nlm.nih.gov/pubmed/33807002 http://dx.doi.org/10.3390/children8030251 |
Ejemplares similares
-
Structural Analysis of the Effect of Asn107Ser Mutation on Alg13 Activity and Alg13-Alg14 Complex Formation and Expanding the Phenotypic Variability of ALG13-CDG
por: Mitusińska, Karolina, et al.
Publicado: (2022) -
NMR-based metabolomics in pediatric drug resistant epilepsy – preliminary results
por: Boguszewicz, Łukasz, et al.
Publicado: (2019) -
Anthropometric Phenotype of Patients with PMM2-CDG
por: Lipiński, Patryk, et al.
Publicado: (2021) -
ATP6AP1‐CDG: Follow‐up and female phenotype
por: Lipiński, Patryk, et al.
Publicado: (2020) -
Characteristics of Neuroimaging and Behavioural Phenotype in Polish Patients with PIGV-CDG—An Observational Study and Literature Review
por: Hutny, Michal, et al.
Publicado: (2023)